AstraZeneca Announces Departure of Lu Yanbin, Deputy Director of Strategic Project Management Office

Recently, AstraZeneca announced internally: Lu Yanbin, the current Deputy Director of the Strategic Project Management Office, will leave the company to seek external development opportunities for personal reasons.Effective immediately, Yu Qiran, the current Market Director of New Product Planning, will also serve as the Head of the Oncology General Manager Project Management Office. He will lead the team in formulating oncology business strategies, accelerating the introduction of new products, establishing cross-departmental and external collaborations, while driving internal cooperation within the Oncology Business Unit and executing strategic projects at the Oncology Business Unit level.The team will be renamed the Strategy and New Product Planning Department after the merger, and Yu Qiran will continue to report directly to Chen Kangwei, General Manager of the Oncology Business Unit.

Source: Pharmaceutical Economist